In the last trading session, 2.64 million Xeris Biopharma Holdings Inc (NASDAQ:XERS) shares changed hands as the company’s beta touched 0.69. With the company’s per share price at $5.08 changed hands at $0.21 or 4.31% during last session, the market valuation stood at $813.58M. XERS’s last price was a discount, traded about -19.49% off its 52-week high of $6.07. The share price had its 52-week low at $1.86, which suggests the last value was 63.39% up since then.
Analysts gave the Xeris Biopharma Holdings Inc (XERS) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.33. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended XERS as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight.
Xeris Biopharma Holdings Inc (NASDAQ:XERS) trade information
Instantly XERS was in green as seen at the end of in last trading. With action 3.67%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 49.85%, with the 5-day performance at 3.67% in the green. However, in the 30-day time frame, Xeris Biopharma Holdings Inc (NASDAQ:XERS) is 26.37% up.
The consensus price target for the stock as assigned by Wall Street analysts is 4, meaning bulls need a downside of -27.0% from its current market value. According to analyst projections, XERS’s forecast low is 4 with 4 as the target high. To hit the forecast high, the stock’s price needs a 21.26% surge from its current level, while the stock would need to tank 21.26% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 40.01%. The 2025 estimates are for Xeris Biopharma Holdings Inc earnings to increase by 79.28%.
XERS Dividends
Xeris Biopharma Holdings Inc is expected to release its next quarterly earnings report in June.
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 5.1615% or 7.66 million shares worth $17.23 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF . With 4.22 shares estimated at $21.44 million under it, the former controlled 2.70% of total outstanding shares. On the other hand, iShares Trust-iShares Russell 2000 ETF held about 2.37% of the shares, roughly 3.71 shares worth around $18.83 million.
